Condition
Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma|Stage IA Malignant Mesothelioma|Stage IB Malignant Mesothelioma|Stage II Malignant Mesothelioma|Stage III Malignant Mesothelioma|Stage IV Malignant Mesothelioma
Estimated Enrollment: 44
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCI-2012-02813|CALGB-30307|CDR0000415372|U10CA031946
Study First Received: April 5, 2005
Last Updated: June 4, 2013
Estimated Primary Completion Date: June 2007
Primary Outcome Measures:
Response rate (including complete and partial response)|Time to tumor progression|Percentage of patients remaining failure-free|Overall survival
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00107432
